CROss Alliance® align itself with the new Swiss clinical regulations

October 2024 – Switzerland has revised its clinical research regulations, with the new framework taking effect from 1^st November 2024.

While the regulation body remain substantially similar to the previous one, these changes strengthen participant protections and enhance research conditions, focusing on digitalization, improved project quality, and transparency while promoting a supportive environment for innovation.

Key updates include:

• Digital consent for streamlined participant approval.
• Enhanced data standards and extended data retention for clinical trials to 20 years.
• Alignment with certain EU standards to facilitate international research.
• Stronger participant rights, with greater result transparency.
• Inclusive research requiring the representation of diverse population subgroups, such as different sexes and age categories.

CROSS is ready to guide your trials through these new regulations and requirements with the usual commitment we dedicate to our customers.

In addition, being CROSS Research a GCP Training Provider at Investigator level, officially recognised by Swissethics, our QA Unit already updated the related GCP course.